Clinical Trial

European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)

Study acronym: EUROASPIRE VI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 10, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to provide a unique European picture of preventive action by cardiologists, other specialists and primary care physicians looking after patients with coronary heart disease (CHD), individuals at high cardiovascular disease risk and all those with hypertension, dyslipidaemia (including familial hypercholesterolaemia), diabetes and dysglycaemia and chronic kidney disease (CKD) and determine whether the European guidelines on cardiovascular disease prevention, hypertension, lipids, diabetes and chronic kidney disease are being followed.
Trial Details
NCT Number NCT06495177
Lead Sponsor European Society of Cardiology
Collaborators: National Institute for Prevention and Cardiovascular Health, Ireland
Conditions Coronary Disease, Acute Coronary Syndrome, Unstable Angina, ST Elevation Myocardial Infarction, Non-ST Elevation Myocardial Infarction
Enrollment 8,000 participants
Start Date 2024-06-07
Primary Completion 2025-08 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-10